Nicolas Lachance

High Rates of HIV Infection among Injection Drug Users Participating in Needle Exchange Programs in Montreal: Results of a Cohort Study

Julie Bruneau, F Lamothe, Eduardo L. Franco et al. · American Journal of Epidemiology · 1997 · 308 citations

Public Health, Infectious Disease Control, Preventive Medicine +13

Discovery of a Potent and Selective Prostaglandin D₂ Receptor Antagonist, [(3<i>R</i>)-4-(4-Chloro- benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[<i>b</i>]indol-3-yl]-acetic Acid (MK-0524)

Claudio F. Sturino, Gary P. O’Neill, Nicolas Lachance et al. · Journal of Medicinal Chemistry · 2007 · 170 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +8

Prostaglandin Receptor EP₄ Mediates the Bone Anabolic Effects of PGE₂

M. Machwate, Satoru Harada, Chih‐Tai Leu et al. · Molecular Pharmacology · 2001 · 167 citations

Medicine, Cell Biology, Pharmacology +16

Development of a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor (MK-8245) to Establish a Therapeutic Window for the Treatment of Diabetes and Dyslipidemia

Renata M. Oballa, Liette Belair, W. Cameron Black et al. · Journal of Medicinal Chemistry · 2011 · 142 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Facile access to 4-aryl-2(5H)-furanones by Suzuki cross coupling: Efficient synthesis of rubrolides C and E

John Boukouvalas, Nicolas Lachance, Michel Ouellet et al. · Tetrahedron Letters · 1998 · 70 citations

Natural Sciences, Chemistry, Organic Chemistry +8